Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial

Creators: Toby M. Maher; Maureen D. Mayes; Michael Kreuter; Elizabeth R. Volkmann; Martin Aringer; Ivan Castellvi; Maurizio Cutolo; Christian Stock; Nils Schoof; Margarida Alves; Ganesh Raghu; the SENSCIS Trial Investigators

Others:: Maher, Toby M.; Mayes, Maureen D.; Kreuter, Michael; Volkmann, Elizabeth R.; Aringer, Martin; Castellvi, Ivan; Cutolo, Maurizio; Stock, Christian; Schoof, Nil; Alves, Margarida; Raghu, Ganesh; SENSCIS Trial Investigators, The

Additional details